Redmond Asset Management, LLC Kiromic Biopharma, Inc. Transaction History

Redmond Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.26 - $10.2 $684 - $26,866	-2,634 Reduced 5.93%	41,758 $12,000
Q2 2022 Aug 10, 2022	SELL	$0.26 - $0.87 $1,791 - $5,995	-6,891 Reduced 13.44%	44,392 $19,000
Q1 2022 May 03, 2022	BUY	$0.6 - $1.82 $1,963 - $5,956	3,273 Added 6.82%	51,283 $44,000
Q4 2021 Feb 04, 2022	BUY	$1.53 - $3.12 $2,509 - $5,116	1,640 Added 3.54%	48,010 $73,000
Q3 2021 Oct 22, 2021	BUY	$2.69 - $4.94 $2,781 - $5,107	1,034 Added 2.28%	46,370 $142,000
Q2 2021 Aug 11, 2021	SELL	$4.81 - $10.34 $365 - $785	-76 Reduced 0.17%	45,336 $218,000
Q1 2021 May 06, 2021	BUY	$8.2 - $11.81 $372,378 - $536,315	45,412 New	45,412 $425,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $15.8M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.